|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US9585920B2
(en)
|
2011-02-04 |
2017-03-07 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
|
US9457077B2
(en)
|
2009-11-18 |
2016-10-04 |
Katherine Rose Kovarik |
Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
|
|
WO2011094027A1
(en)
|
2010-02-01 |
2011-08-04 |
Hlavka Edwin J |
Bacteriotherapy for clostridium difficile colitis
|
|
WO2011103274A1
(en)
*
|
2010-02-17 |
2011-08-25 |
Gen-Probe Incorporated |
Compositions and methods to detect atopobium vaginae nucleic acid
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
KR102435108B1
(ko)
|
2010-08-04 |
2022-08-22 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
|
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
US10548761B2
(en)
|
2011-02-04 |
2020-02-04 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US10687975B2
(en)
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US10111913B2
(en)
|
2011-02-04 |
2018-10-30 |
Joseph E. Kovarik |
Method of reducing the likelihood of skin cancer in an individual human being
|
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
US10010568B2
(en)
|
2011-02-04 |
2018-07-03 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a spirochetes infection in a human being
|
|
US10835560B2
(en)
|
2013-12-20 |
2020-11-17 |
Joseph E. Kovarik |
Reducing the likelihood of skin cancer in an individual human being
|
|
US10085938B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for preventing sore throat in humans
|
|
US12533312B2
(en)
|
2011-02-04 |
2026-01-27 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US9987224B2
(en)
|
2011-02-04 |
2018-06-05 |
Joseph E. Kovarik |
Method and system for preventing migraine headaches, cluster headaches and dizziness
|
|
US10314865B2
(en)
|
2011-02-04 |
2019-06-11 |
Katherine Rose Kovarik |
Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
|
|
US10086018B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US9730967B2
(en)
|
2011-02-04 |
2017-08-15 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US11357722B2
(en)
|
2011-02-04 |
2022-06-14 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
CN103561752B
(zh)
|
2011-03-09 |
2016-04-20 |
明尼苏达大学评议会 |
用于移植结肠微生物群的组合物和方法
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
EP2785828B1
(en)
|
2011-12-01 |
2020-04-08 |
The University of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
WO2013130773A2
(en)
|
2012-02-29 |
2013-09-06 |
Ethicon Endo-Surgery, Inc. |
Compositions of microbiota and methods related thereto
|
|
US20150086581A1
(en)
*
|
2012-03-17 |
2015-03-26 |
The Regents Of The University Of California |
Fast Diagnosis and Personalized Treatment for Acne
|
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
|
JP6203816B2
(ja)
|
2012-03-29 |
2017-09-27 |
セラバイオーム，エルエルシー |
回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
|
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
JP2015522554A
(ja)
|
2012-06-04 |
2015-08-06 |
サンコー・エナジー・インコーポレーテッド |
パラフィン油及び沈降防止剤を含む製剤
|
|
EP2890808A4
(en)
|
2012-08-29 |
2016-09-28 |
California Inst Of Techn |
DIAGNOSIS AND TREATMENT OF AUTISTICAL DISEASES
|
|
NZ709392A
(en)
|
2012-11-23 |
2016-10-28 |
Seres Therapeutics Inc |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US11185562B2
(en)
|
2013-02-04 |
2021-11-30 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
|
AU2014239883B2
(en)
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
HK1220326A1
(zh)
|
2013-03-15 |
2017-05-05 |
Seres Therapeutics, Inc. |
基於网络微生物组成和方法
|
|
US20160286801A1
(en)
|
2013-03-15 |
2016-10-06 |
Suncor Energy Inc. |
Herbicidal Compositions
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
EP4234011A3
(en)
|
2013-06-05 |
2023-09-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
WO2015013214A2
(en)
|
2013-07-21 |
2015-01-29 |
Whole Biome, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
|
MX367109B
(es)
|
2013-11-25 |
2019-08-05 |
Seres Therapeutics Inc |
Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
|
|
WO2015095241A2
(en)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
US12318377B2
(en)
|
2013-12-20 |
2025-06-03 |
Seed Health, Inc. |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
AU2015227075A1
(en)
*
|
2014-03-06 |
2016-09-22 |
Ohio State Innovation Foundation |
Probiotic formulations and methods for use
|
|
US10624934B2
(en)
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
|
US9783858B2
(en)
*
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
|
US10766799B2
(en)
|
2014-05-23 |
2020-09-08 |
Nch Corporation |
Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
|
|
FI127671B
(en)
|
2014-05-28 |
2018-11-30 |
Filip Scheperjans |
Method for diagnostics of Parkinson’s disease
|
|
US20160016002A1
(en)
*
|
2014-07-17 |
2016-01-21 |
John Todd Kuenstner |
Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Probiotics
|
|
ES2672045T3
(es)
*
|
2014-07-25 |
2018-06-12 |
Biosynth S.R.L. |
Vacunas de productos glicoconjugados que comprenden unidades básicas de una construcción molecular que expresa múltiples epítopos incorporados para la formulación de una vacuna de amplio espectro contra infecciones debidas a bacterias enteropatógenas
|
|
AU2015299053B2
(en)
|
2014-08-04 |
2021-10-21 |
Basf Se |
Antifungal Paenibacillus strains, fusaricidin-type compounds, and their use
|
|
US10900043B2
(en)
|
2014-09-02 |
2021-01-26 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for treating bacterial disease
|
|
US10286016B2
(en)
|
2014-09-02 |
2019-05-14 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for treating gonorrhea
|
|
JP6487534B2
(ja)
|
2014-09-05 |
2019-03-20 |
シンビオミックス セラピューティクス、エルエルシー |
細菌性膣炎の治療に使用するためのセクニダゾール
|
|
US10046030B2
(en)
|
2014-10-07 |
2018-08-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
|
US9710606B2
(en)
|
2014-10-21 |
2017-07-18 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
|
US10073952B2
(en)
|
2014-10-21 |
2018-09-11 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
|
|
EP3209803A4
(en)
|
2014-10-21 |
2018-06-13 |
Ubiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics
|
|
US10777320B2
(en)
|
2014-10-21 |
2020-09-15 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
|
|
US9758839B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
|
|
US10346592B2
(en)
|
2014-10-21 |
2019-07-09 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
|
US10311973B2
(en)
|
2014-10-21 |
2019-06-04 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
|
|
US10395777B2
(en)
|
2014-10-21 |
2019-08-27 |
uBiome, Inc. |
Method and system for characterizing microorganism-associated sleep-related conditions
|
|
US10409955B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions
|
|
US9760676B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
|
|
US10169541B2
(en)
|
2014-10-21 |
2019-01-01 |
uBiome, Inc. |
Method and systems for characterizing skin related conditions
|
|
US10357157B2
(en)
|
2014-10-21 |
2019-07-23 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
|
|
US10325685B2
(en)
|
2014-10-21 |
2019-06-18 |
uBiome, Inc. |
Method and system for characterizing diet-related conditions
|
|
US10265009B2
(en)
|
2014-10-21 |
2019-04-23 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
|
|
US10410749B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
|
|
US10793907B2
(en)
|
2014-10-21 |
2020-10-06 |
Psomagen, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
|
|
US9754080B2
(en)
|
2014-10-21 |
2017-09-05 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions
|
|
CA2966363A1
(en)
|
2014-10-30 |
2016-05-06 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
|
CN107106616A
(zh)
|
2014-10-30 |
2017-08-29 |
加利福尼亚技术学院 |
包括改善神经发育障碍行为的细菌的组合物和方法
|
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
|
AU2015353465B2
(en)
*
|
2014-11-25 |
2021-07-29 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and GVHD
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
WO2016103005A1
(en)
|
2014-12-23 |
2016-06-30 |
Institut Pasteur |
Method of culturing segmented filamentous bacteria in vitro
|
|
WO2016105498A1
(en)
|
2014-12-23 |
2016-06-30 |
Synthetic Biologics, Inc. |
Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
|
|
KR20170091157A
(ko)
|
2014-12-23 |
2017-08-08 |
4디 파마 리서치 리미티드 |
피린 폴리펩티드 및 면역 조정
|
|
PL3065748T3
(pl)
|
2014-12-23 |
2018-07-31 |
4D Pharma Research Limited |
Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia
|
|
US20180021387A1
(en)
*
|
2015-02-06 |
2018-01-25 |
Western University Of Health Sciences |
Probiotic compositions and methods of use
|
|
AU2016229976B2
(en)
|
2015-03-06 |
2021-11-11 |
Theriva Biologics, Inc. |
Safe and effective beta-lactamase dosing for microbiome protection
|
|
WO2016141454A1
(en)
*
|
2015-03-12 |
2016-09-15 |
The University Of British Columbia |
Bacterial compositions and methods of use thereof
|
|
EP3270706B1
(en)
*
|
2015-03-16 |
2024-10-30 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Enriched animal feed composition comprising archaebacteria
|
|
MX381965B
(es)
|
2015-04-03 |
2025-03-13 |
Quest Diagnostics Invest Inc |
Ensayo para detección de cepas patogénicas de leptospira.
|
|
US10246753B2
(en)
|
2015-04-13 |
2019-04-02 |
uBiome, Inc. |
Method and system for characterizing mouth-associated conditions
|
|
EP3283085A4
(en)
*
|
2015-04-13 |
2019-04-10 |
Ubiome, Inc. |
METHOD AND SYSTEM FOR MICROBIBLE DERIVED DIAGNOSIS AND THERAPEUTIC FOR DISEASES RELATED TO TAXONOMIC MICROBIAL MATERIALS
|
|
WO2016168354A1
(en)
*
|
2015-04-13 |
2016-10-20 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
|
|
CN107835692B
(zh)
*
|
2015-04-13 |
2022-08-02 |
普梭梅根公司 |
用于皮肤系统状况的微生物组来源的表征、诊断和治疗的方法及系统
|
|
EP3283087A4
(en)
*
|
2015-04-14 |
2019-03-13 |
Ubiome Inc. |
METHOD AND SYSTEM FOR MICROBIOMEDIVED DIAGNOSTICS AND THERAPEUTICS FOR DISEASES OF THE ENDOCRINE SYSTEM
|
|
US12050161B2
(en)
|
2015-04-24 |
2024-07-30 |
Maat Pharma |
Microorganism sampling method, microorganism sampling device and sampling kit comprising such a sampling device
|
|
FR3035328B1
(fr)
|
2015-04-24 |
2019-08-23 |
Maat Pharma |
Procede de preparation d'un echantillon de microbiote fecal
|
|
FR3035317B1
(fr)
|
2015-04-24 |
2019-06-14 |
Maat Pharma |
Dispositif de prelevement de micro-organismes, kit de prelevement comprenant un tel dispositif et procede de prelevement mettant en œuvre un tel dispositif
|
|
CA2985827A1
(en)
*
|
2015-05-14 |
2016-11-17 |
Crestovo Holdings Llc |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
NZ776366A
(en)
|
2015-05-22 |
2023-02-24 |
Univ Minnesota |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US11253501B2
(en)
|
2015-06-01 |
2022-02-22 |
Lupin Inc. |
Secnidazole formulations and use in treating bacterial vaginosis
|
|
CN105067731B
(zh)
*
|
2015-06-05 |
2017-06-16 |
中国农业科学院兰州兽医研究所 |
一种弓形虫感染后血清中生物标记物的筛选方法及筛选出的生物标记物的应用
|
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
|
CN107921072A
(zh)
*
|
2015-06-09 |
2018-04-17 |
雷柏奥提斯有限公司 |
微生物群恢复治疗（mrt）组合物和制造方法
|
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
SI3240554T1
(sl)
|
2015-06-15 |
2019-12-31 |
4D Pharma Research Limited, |
Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
|
|
MD3650033T2
(ro)
|
2015-06-15 |
2022-08-31 |
4D Pharma Res Ltd |
Compoziții conţinând tulpini bacteriene
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
EA201890050A1
(ru)
|
2015-06-15 |
2018-06-29 |
4Д Фарма Рисёрч Лимитед |
Композиции, содержащие бактериальные штаммы
|
|
AU2016282996A1
(en)
|
2015-06-25 |
2018-01-18 |
Ascus Biosciences, Inc. |
Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
|
US9938558B2
(en)
|
2015-06-25 |
2018-04-10 |
Ascus Biosciences, Inc. |
Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
|
US10632157B2
(en)
|
2016-04-15 |
2020-04-28 |
Ascus Biosciences, Inc. |
Microbial compositions and methods of use for improving fowl production
|
|
US10851399B2
(en)
|
2015-06-25 |
2020-12-01 |
Native Microbials, Inc. |
Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
|
CA3006380A1
(en)
*
|
2015-07-08 |
2017-01-12 |
Seres Therapeutics, Inc. |
Methods of treating colitis
|
|
CA2993009A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
HK1258531A1
(zh)
*
|
2015-08-24 |
2019-11-15 |
努比约塔有限公司 |
使用粪源细菌群落来治疗微生态失衡的系统和方法
|
|
CN113975395A
(zh)
*
|
2015-09-04 |
2022-01-28 |
纪念斯隆-凯特琳癌症中心 |
用于检测癌症复发风险的方法和组合物
|
|
WO2017044885A1
(en)
*
|
2015-09-09 |
2017-03-16 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health
|
|
WO2017053544A1
(en)
*
|
2015-09-22 |
2017-03-30 |
Mayo Foundation For Medical Education And Research |
Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection
|
|
WO2017049352A1
(en)
*
|
2015-09-24 |
2017-03-30 |
Agriculture Victoria Services Pty Ltd |
Brachiaria endophytes and related methods
|
|
RU2709464C2
(ru)
|
2015-09-29 |
2019-12-18 |
Кимберли-Кларк Ворлдвайд, Инк. |
Синергическая композиция для сохранения здорового баланса микрофлоры
|
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
|
IL298281A
(en)
*
|
2015-11-03 |
2023-01-01 |
Brigham & Womens Hospital Inc |
Medical microbiota for the treatment and/or prevention of food allergy
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
AU2016357554B2
(en)
|
2015-11-20 |
2019-04-04 |
Cj Bioscience, Inc. |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
EP4233884A3
(en)
*
|
2015-11-24 |
2023-10-04 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
|
US10675347B2
(en)
|
2015-11-30 |
2020-06-09 |
Joseph E. Kovarik |
Method and system for protecting honey bees from fipronil pesticides
|
|
US10568916B2
(en)
|
2015-11-30 |
2020-02-25 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US10933128B2
(en)
|
2015-11-30 |
2021-03-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees from pesticides
|
|
US11529412B2
(en)
|
2015-11-30 |
2022-12-20 |
Seed Health, Inc. |
Method and system for protecting honey bees from pesticides
|
|
US10086024B2
(en)
|
2015-11-30 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US12239706B2
(en)
|
2015-11-30 |
2025-03-04 |
Seed Health, Inc. |
Method and system for protecting monarch butterflies from pesticides
|
|
WO2017100420A1
(en)
*
|
2015-12-08 |
2017-06-15 |
Mayo Foundation For Medical Education And Research |
Biomarkers for predicting clostridium difficile infection treatment outcome
|
|
FR3045383B1
(fr)
*
|
2015-12-18 |
2019-06-14 |
Maat Pharma |
Procede de lyophilisation d'un echantillon de microbiote fecal
|
|
CA3010505A1
(en)
|
2016-01-07 |
2017-07-13 |
Ascus Biosciences, Inc. |
Methods for improving milk production by administration of microbial consortia
|
|
CN106974940B
(zh)
*
|
2016-01-15 |
2020-08-25 |
深圳华大生命科学研究院 |
厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
|
|
IL243707A0
(en)
|
2016-01-20 |
2016-05-01 |
Galmed Res And Dev Ltd |
Treatment to regulate the microbiota in the intestine
|
|
FI3639834T3
(fi)
*
|
2016-02-04 |
2023-09-27 |
Univ Gent |
Mikrobiyhteisöjen käyttö ihmisen ja eläimen terveyttä varten
|
|
WO2017137834A1
(en)
*
|
2016-02-08 |
2017-08-17 |
University Of Oslo |
Bacterial growth media
|
|
EP3205209A1
(en)
|
2016-02-09 |
2017-08-16 |
Basf Se |
Mixtures and compositions comprising paenibacillus strains or metabolites thereof and other biopesticides
|
|
EP3520801A1
(en)
|
2016-03-04 |
2019-08-07 |
4D Pharma Plc |
Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
|
|
EP4249053A3
(en)
|
2016-03-04 |
2024-06-19 |
The Regents of The University of California |
Microbial consortium and uses thereof
|
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
WO2017160711A1
(en)
|
2016-03-14 |
2017-09-21 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
MX2018011413A
(es)
*
|
2016-03-24 |
2019-01-10 |
Paratek Pharm Innc |
Metodos para tratar y prevenir infeccion por c. difficile.
|
|
US12097226B2
(en)
|
2016-04-05 |
2024-09-24 |
Nch Corporation |
System and method for using a single-serve nutrient spore composition for small scale farm applications
|
|
MX2018012060A
(es)
*
|
2016-04-05 |
2019-03-06 |
Nch Corp |
Composicion rica en nutriente germinante y metodo de incubacion de esporas.
|
|
US10897922B2
(en)
|
2016-04-05 |
2021-01-26 |
Nch Corporation |
Composition and method for germinative compounds in probiotic food and beverage products for human consumption
|
|
CA3020833A1
(en)
|
2016-04-15 |
2017-10-19 |
Ascus Biosciences, Inc. |
Methods for improving agricultural production of fowl by administration of microbial consortia or purified strains thereof
|
|
US11786562B2
(en)
*
|
2016-04-19 |
2023-10-17 |
Genome Research Limited |
Bacteriotherapy
|
|
JP2019514885A
(ja)
|
2016-04-21 |
2019-06-06 |
ネイキッド バイオーム，インク． |
皮膚障害の処置のための組成物および方法
|
|
US10252145B2
(en)
|
2016-05-02 |
2019-04-09 |
Bao Tran |
Smart device
|
|
CN109642904A
(zh)
|
2016-05-23 |
2019-04-16 |
加州理工学院 |
调节肠微生物群来治疗神经退行性病症
|
|
WO2017210428A1
(en)
*
|
2016-06-01 |
2017-12-07 |
Crestovo Llc |
Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders
|
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
|
ES2960053T3
(es)
*
|
2016-06-14 |
2024-02-29 |
Vedanta Biosciences Inc |
Tratamiento de infección por Clostridium difficile
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
WO2017218889A1
(en)
*
|
2016-06-16 |
2017-12-21 |
Ohio State Innovation Foundation |
Eubacterium probiotics and methods of treating or preventing heart disease
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
GB201703548D0
(en)
*
|
2017-03-06 |
2017-04-19 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
GB201703552D0
(en)
*
|
2017-03-06 |
2017-04-19 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
TW201821093A
(zh)
*
|
2016-07-13 |
2018-06-16 |
英商４Ｄ製藥有限公司 |
包含細菌菌株之組合物
|
|
AU2017295861A1
(en)
*
|
2016-07-13 |
2019-01-24 |
Psomagen, Inc. |
Method and system for microbial pharmacogenomics
|
|
KR101815692B1
(ko)
*
|
2016-07-25 |
2018-01-16 |
주식회사 고바이오랩 |
구강 세균의 군집을 이용한 대사성 질환 진단용 바이오 마커
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
WO2018031545A1
(en)
*
|
2016-08-11 |
2018-02-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for detecting oral squamous cell carcinomas
|
|
WO2018046485A1
(en)
|
2016-09-09 |
2018-03-15 |
Swecure Ab |
Use of butyricimonas and/or oxalobacter for treating irritable bowel syndrome
|
|
US11026978B2
(en)
|
2016-10-11 |
2021-06-08 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
JP6927512B2
(ja)
*
|
2016-10-26 |
2021-09-01 |
地方独立行政法人神奈川県立産業技術総合研究所 |
物体表面の抗菌性試験用菌液媒体
|
|
EP3551201A4
(en)
*
|
2016-12-06 |
2020-06-24 |
Pendulum Therapeutics, Inc. |
METHODS AND COMPOSITIONS ASSOCIATED WITH INSULATED AND PURIFIED MICROBES
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
AU2017376780B2
(en)
|
2016-12-15 |
2024-12-12 |
Novome Biotechnologies, Inc. |
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
|
|
JP2020501570A
(ja)
*
|
2016-12-16 |
2020-01-23 |
ヴェダンタ バイオサイエンシーズ インコーポレーテッドＶｅｄａｎｔａ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． |
細菌完全性を決定するための方法および組成物
|
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
|
IL296740B2
(en)
*
|
2016-12-23 |
2023-09-01 |
Univ Keio |
Compositions and methods for the induction of cd8+ t-cells
|
|
AU2017388535A1
(en)
|
2016-12-28 |
2019-07-25 |
Native Microbials, Inc. |
Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles including dosed microbial ensembles and inoculative microbial ensembles
|
|
CN110366596A
(zh)
|
2016-12-28 |
2019-10-22 |
埃斯库斯生物科技股份公司 |
用于对复杂异质群落中的完整微生物株系进行分析、确定其功能关系及相互作用以及基于此来识别和合成生物活性改性剂的方法、设备和系统
|
|
WO2018129249A1
(en)
*
|
2017-01-05 |
2018-07-12 |
The University Of Chicago |
Inhibition of enteric infection through the modulation of microbiota
|
|
CN107058490B
(zh)
*
|
2017-01-12 |
2018-03-06 |
杨俊杰 |
肠道及口腔菌群多样性及差异性的分析方法
|
|
US10381105B1
(en)
|
2017-01-24 |
2019-08-13 |
Bao |
Personalized beauty system
|
|
US12029748B2
(en)
|
2017-02-28 |
2024-07-09 |
Kimberly-Clark Worldwide, Inc. |
Synergistic composition for maintenance of healthy balance of microflora
|
|
US10052026B1
(en)
|
2017-03-06 |
2018-08-21 |
Bao Tran |
Smart mirror
|
|
EP3606325B1
(en)
|
2017-04-03 |
2024-09-04 |
Gusto Global, LLC |
Rational design of microbial-based biotherapeutics
|
|
US11040073B2
(en)
|
2017-04-05 |
2021-06-22 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
|
CA3058818A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
|
EP3388069B1
(en)
|
2017-04-12 |
2019-05-01 |
ETH Zurich |
Consortia of living bacteria useful for treatment of microbiome dysbiosis
|
|
WO2018201049A1
(en)
|
2017-04-28 |
2018-11-01 |
Ascus Biosciences, Inc. |
Methods for supporting grain intensive and/or energy intensive diets in ruminants with a synthetic bioensemble of microbes
|
|
US11147792B2
(en)
|
2017-05-15 |
2021-10-19 |
Axial Therapeutics, Inc. |
Inhibitors of microbially induced amyloid
|
|
JP7212945B2
(ja)
|
2017-05-22 |
2023-01-26 |
フォーディー ファーマ リサーチ リミテッド |
細菌株を含む組成物
|
|
TW201907931A
(zh)
|
2017-05-24 |
2019-03-01 |
英商4D製藥研究有限公司 |
包含細菌菌株之組合物
|
|
CA3064773A1
(en)
|
2017-05-26 |
2018-11-29 |
Crestovo Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
|
WO2018229188A1
(en)
|
2017-06-14 |
2018-12-20 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
CN115813955A
(zh)
|
2017-06-14 |
2023-03-21 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
|
MD3804737T2
(ro)
|
2017-06-14 |
2022-10-31 |
4D Pharma Res Limited |
Compoziții care conțin tulpini bacteriene
|
|
WO2018236979A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Cornell University |
Probiotic compositions and methods
|
|
CN107854495B
(zh)
*
|
2017-08-04 |
2021-04-13 |
青岛东海药业有限公司 |
凝结芽孢杆菌在制备降低血尿酸制剂中的应用
|
|
US20200376044A1
(en)
*
|
2017-08-04 |
2020-12-03 |
Tarunmeet GUJRAL |
Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeutics
|
|
AU2018314228A1
(en)
*
|
2017-08-06 |
2020-03-05 |
Second Genome, Inc. |
Streptococcus Australis as a biotherapeutics
|
|
CA3072032A1
(en)
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
|
WO2019032575A1
(en)
*
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
TREATMENT OF LIVER DISEASE BY MODULATION OF MICROBIOMA
|
|
SG11202001142VA
(en)
|
2017-08-14 |
2020-03-30 |
Axcella Health Inc |
Amino acid compositions for the treatment of liver disease
|
|
AU2018318132B2
(en)
|
2017-08-14 |
2025-06-26 |
Seres Therapeutics, Inc. |
Compositions and methods for treating cholestatic disease
|
|
TWI640314B
(zh)
*
|
2017-08-22 |
2018-11-11 |
長庚生物科技股份有限公司 |
戈氏副擬桿菌用於降低胰島素抗性及提升葡萄糖耐受性之用途
|
|
WO2019043051A1
(en)
|
2017-08-29 |
2019-03-07 |
Chr. Hansen A/S |
STABLE CAPSULES COMPRISING A FECAL MICROBIOTE OR A CULTURE OF MICROORGANISMS
|
|
US11241461B2
(en)
|
2017-08-29 |
2022-02-08 |
Evelo Biosciences, Inc. |
Treating cancer using a blautia strain
|
|
WO2019046646A1
(en)
|
2017-08-30 |
2019-03-07 |
Whole Biome Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
|
|
EP3453395B1
(en)
|
2017-09-08 |
2023-10-18 |
Deutsches Rheuma-Forschungszentrum Berlin |
Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system
|
|
CN111148531A
(zh)
|
2017-09-08 |
2020-05-12 |
伊夫罗生物科学公司 |
细菌胞外囊泡
|
|
EP3688196A4
(en)
*
|
2017-09-26 |
2021-07-14 |
Second Genome, Inc. |
GEMELLA SANGUINIS AS BIOTHERAPEUTICS
|
|
EP3697230A4
(en)
|
2017-10-18 |
2022-04-13 |
Native Microbials, Inc. |
IMPROVING POULTRY PRODUCTION BY ADMINISTRATION OF A SYNTHETIC BIOENSEMBLE OF MICROBES OR PURIFIED STRAIN THEREOF
|
|
EP3703720A1
(en)
|
2017-10-30 |
2020-09-09 |
Seres Therapeutics, Inc. |
Compositions and methods for treating antibiotic resistance
|
|
FI128395B
(en)
|
2017-11-09 |
2020-04-30 |
Kemira Oyj |
Method for making a fibrous web
|
|
CN107653243B
(zh)
*
|
2017-11-15 |
2021-06-15 |
中国农业科学院农业基因组研究所 |
一种从肠道内容物中提取微生物宏基因组dna的方法
|
|
CA3084954A1
(en)
|
2017-12-05 |
2019-06-13 |
BioPlx, Inc. |
Methods and compositions to prevent microbial infection
|
|
CN107828705A
(zh)
*
|
2017-12-31 |
2018-03-23 |
佛山市艳晖生物科技有限公司 |
一株解淀粉芽孢杆菌及其在防治孤独症上的应用
|
|
TWI813620B
(zh)
*
|
2018-02-02 |
2023-09-01 |
香港中文大學 |
糞便微生物群移植的糞便真菌微生物和治療功效
|
|
US11730772B2
(en)
*
|
2018-02-09 |
2023-08-22 |
Noster Inc. |
Lipopolysaccharide-regulated enteric bacteria and use thereof
|
|
WO2019156234A1
(en)
*
|
2018-02-09 |
2019-08-15 |
Keio University |
Compositions and methods for the induction of cd8+ t-cells
|
|
CN110211629A
(zh)
*
|
2018-02-11 |
2019-09-06 |
中国科学院昆明动物研究所 |
一种评估微生物群落宏基因（或普通生物群落宏遗传）多样性和相似性的概念和方法
|
|
ES3032290T3
(en)
|
2018-03-20 |
2025-07-16 |
Theriva Biologics Inc |
Intestinal alkaline phosphatase formulations
|
|
MX2020010177A
(es)
*
|
2018-03-29 |
2021-01-15 |
Seres Therapeutics Inc |
Composiciones y métodos para tratar enfermedades inflamatorias intestinales.
|
|
WO2019199895A1
(en)
|
2018-04-10 |
2019-10-17 |
Siolta Therapeutics, Inc. |
Microbial consortia
|
|
EP3773642A4
(en)
|
2018-04-13 |
2022-03-02 |
White Dog Labs, Inc. |
IMPROVED METHOD OF SELECTING PROBIOTICS
|
|
KR102225939B1
(ko)
*
|
2018-04-19 |
2021-03-10 |
주식회사 고바이오랩 |
신규한 Bacteroides vulgatus 균주 및 이를 유효 성분으로 하는 면역 및 대사성 질환 예방 또는 치료용 조성물
|
|
CA3097038A1
(en)
*
|
2018-04-30 |
2019-11-07 |
Suncor Energy Inc. |
Macrocyclic tetrapyrrole compounds, compositions and methods for increasing abiotic stress resistance in plants
|
|
CN110468061B
(zh)
*
|
2018-05-11 |
2024-03-08 |
韩国亿诺生物有限公司 |
具有预防或治疗癌症的效果的新型菌株
|
|
US11986502B2
(en)
|
2018-05-23 |
2024-05-21 |
Optium, LLC |
Bacteriophage compositions and kits and related methods
|
|
CA3101242A1
(en)
|
2018-05-23 |
2019-11-28 |
Brigham Young University |
Bacteriophage compositions and kits and related methods
|
|
BR112020023933A2
(pt)
*
|
2018-05-24 |
2021-04-27 |
Seres Therapeutics, Inc. |
composições bacterianas projetadas e usos destas
|
|
US20210121511A1
(en)
*
|
2018-05-29 |
2021-04-29 |
Unm Rainforest Innovations |
Virus-like particle compositions and methods of using same
|
|
BR112020024798B1
(pt)
*
|
2018-06-07 |
2023-05-02 |
Artugen Therapeutics Ltd |
Composição compreendendo cepas bacterianas
|
|
KR20240091008A
(ko)
*
|
2018-06-14 |
2024-06-21 |
리바이오틱스, 인코퍼레이티드 |
미생물총 회복 요법 조성물 및 제조 방법
|
|
CA3103064A1
(en)
*
|
2018-06-19 |
2019-12-26 |
4D Pharma Research Ltd |
Dosage form comprising a live biotherapeutic product
|
|
US10596136B2
(en)
|
2018-06-20 |
2020-03-24 |
Axcella Health Inc. |
Compositions and methods for the treatment of fat infiltration in muscle
|
|
EP3594321A1
(en)
*
|
2018-07-10 |
2020-01-15 |
Université catholique de Louvain |
Dusodibacter, a novel bacterial genus of the gastroinstestinal microbiota and uses thereof
|
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
|
JP7811843B2
(ja)
|
2018-07-19 |
2026-02-06 |
ペンデュラム セラピューティクス， インコーポレイテッド |
微生物生着のための方法および組成物
|
|
US12226433B2
(en)
|
2018-08-06 |
2025-02-18 |
The Johns Hopkins University |
Treatment of irritable bowel syndrome with molybdenum
|
|
JP7558170B2
(ja)
|
2018-08-17 |
2024-09-30 |
ヴェダンタ バイオサイエンシーズ インコーポレーテッド |
腸内毒素症を減少させ、微生物叢を復元する方法
|
|
US12150967B2
(en)
|
2018-08-18 |
2024-11-26 |
Seed Health, Inc. |
Methods and compositions for honey bee health
|
|
WO2020041581A1
(en)
*
|
2018-08-23 |
2020-02-27 |
Cornell University |
Methods and compositions for preventing and treating inflammatory bowel disease and nonalcoholic fatty liver disease
|
|
US11401500B2
(en)
|
2018-08-29 |
2022-08-02 |
Nch Corporation |
System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
|
|
US12144834B2
(en)
|
2018-09-13 |
2024-11-19 |
Xbiome Inc. |
Methods and compositions for treating gastrointestinal and inflammatory disorders
|
|
US12509714B2
(en)
|
2018-09-21 |
2025-12-30 |
Emory University |
Multiple heteroresistance to guide combination antibiotic regimens
|
|
CA3114423A1
(en)
|
2018-09-27 |
2020-04-02 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
|
CN109234195A
(zh)
*
|
2018-09-28 |
2019-01-18 |
邓州市汇海农业科技有限公司 |
一种稻田微生物复合菌剂
|
|
KR102135195B1
(ko)
*
|
2018-10-08 |
2020-07-17 |
아주대학교산학협력단 |
테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
|
|
WO2020074569A1
(en)
*
|
2018-10-09 |
2020-04-16 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
EP3866819A1
(en)
*
|
2018-10-15 |
2021-08-25 |
PharmaBiome AG |
A method of manufacturing a consortium of bacterial strains
|
|
US12569524B2
(en)
|
2018-10-22 |
2026-03-10 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state
|
|
CN113365645A
(zh)
*
|
2018-11-09 |
2021-09-07 |
布里格姆及妇女医院股份有限公司 |
用于治疗和/或预防生态失调的治疗性微生物群
|
|
US12421518B2
(en)
|
2018-12-10 |
2025-09-23 |
Tenza, Inc. |
Methods and compositions for treating hyperoxaluria
|
|
BR112021012767A2
(pt)
*
|
2018-12-28 |
2021-09-21 |
General Probiotics, Inc. |
Composição farmaceuticamente aceitável para o tratamento de um animal e métodos
|
|
MX2021008944A
(es)
|
2019-01-25 |
2021-08-24 |
Suncor Energy Inc |
Compuestos fotosensibilizadores, metodos de fabricacion y aplicacion a las plantas.
|
|
WO2020166708A1
(ja)
*
|
2019-02-15 |
2020-08-20 |
コンビ株式会社 |
新規乳酸菌およびそれを含有する組成物
|
|
AU2020222515B2
(en)
|
2019-02-15 |
2025-10-09 |
Nutrien Ag Solutions (Canada) Inc. |
The use of protoporphyrin IX derivatives to improve the health of plants
|
|
EP3930735A1
(en)
|
2019-02-26 |
2022-01-05 |
The Regents of the University of Colorado, a body corporate |
Method and composition for treating gastrointestinal inflammatory disorders
|
|
CN110195027B
(zh)
*
|
2019-03-08 |
2022-03-01 |
大连理工大学 |
烟草节杆菌zl-1及其堆肥低温发酵菌剂的制备方法与应用
|
|
EP3946608A4
(en)
*
|
2019-03-25 |
2022-12-28 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
METHODS OF TREATMENT OF BOVINE MASTITIS
|
|
WO2020198503A1
(en)
*
|
2019-03-26 |
2020-10-01 |
The Children's Medical Center Corporation |
Therapeutic microbiota for the treatment and/or prevention of dysbiosis
|
|
MX2021013776A
(es)
*
|
2019-05-10 |
2021-12-10 |
4D Pharma Res Limited |
Composiciones que comprenden cepas bacterianas.
|
|
EP3973532A4
(en)
*
|
2019-05-23 |
2022-08-31 |
American Molecular Laboratories, Inc. |
METHODS FOR DETECTING A LEVEL OF H. PYLORI IN A FECAL SAMPLE
|
|
US20220233612A1
(en)
*
|
2019-05-31 |
2022-07-28 |
South Dakota Board Of Regents Technology Transfer Office |
Probiotics to inhibit enteric pathogens
|
|
JP2022535401A
(ja)
|
2019-06-03 |
2022-08-08 |
シンセティック・バイオロジクス・インコーポレイテッド |
アルカリホスファターゼ製剤及びその使用
|
|
KR20220016481A
(ko)
|
2019-06-03 |
2022-02-09 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
패혈증 및 괴사성 장염 유도된 신경발달 결핍의 예방을 위한 프리바이오틱 제형
|
|
CA3147739A1
(en)
*
|
2019-07-17 |
2021-01-21 |
University Of Utah Research Foundation |
Clostridia consortia compositions and methods of treating obesity, metabolic syndrome and irritable bowel disease
|
|
CN110358849A
(zh)
*
|
2019-07-30 |
2019-10-22 |
中国医学科学院北京协和医院 |
源于肠道的诊断胰腺炎的生物标志物、筛选方法及其用途
|
|
WO2021022066A1
(en)
*
|
2019-07-30 |
2021-02-04 |
The Regents Of The University Of California |
Compositions and methods for inhibiting bacterial virulence and flim-based device and method for antibiotic susceptibility testing
|
|
CN112438995A
(zh)
|
2019-09-04 |
2021-03-05 |
台达电子工业股份有限公司 |
抑制具万古霉素抗药性肠球菌的益生菌及其组合与其用途
|
|
AU2020346072A1
(en)
*
|
2019-09-12 |
2022-04-07 |
MarvelBiome, Inc. |
Compositions and methods for characterizing a microbiome
|
|
MX2022002949A
(es)
|
2019-09-24 |
2022-04-06 |
Prolacta Bioscience Inc |
Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
|
|
EP4041264A1
(en)
|
2019-10-07 |
2022-08-17 |
Siolta Therapeutics, Inc. |
Therapeutic pharmaceutical compositions
|
|
WO2021091981A1
(en)
*
|
2019-11-04 |
2021-05-14 |
Vedanta Biosciences, Inc. |
Compositions and methods for enhancing immune checkpoint inhibitor therapy
|
|
CA3159711A1
(en)
*
|
2019-11-27 |
2021-06-03 |
Asuncion Martinez |
Designed bacterial compositions and uses thereof
|
|
KR102215592B1
(ko)
*
|
2019-12-11 |
2021-02-15 |
주식회사 에이치이엠 |
신규한 락토바실러스 퍼멘텀 hem 1036 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
|
|
CN114760976A
(zh)
|
2019-12-16 |
2022-07-15 |
高露洁-棕榄公司 |
含有菊粉的口腔护理组合物
|
|
EP3838276A1
(en)
*
|
2019-12-17 |
2021-06-23 |
Exeliom Biosciences |
Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation
|
|
TWI854077B
(zh)
*
|
2019-12-20 |
2024-09-01 |
瑞士商葛德瑪控股公司 |
生產肉毒桿菌毒素的方法
|
|
US12121553B2
(en)
|
2020-01-27 |
2024-10-22 |
General Probiotics, Inc. |
Compositions including probiotic bacteria for the expression and secretion of enterocins to control clostridia perfringens-induced necrotic enteritis in livestock and related methods
|
|
US11576937B2
(en)
|
2020-02-06 |
2023-02-14 |
Nch Corporation |
Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition
|
|
WO2021163212A1
(en)
*
|
2020-02-10 |
2021-08-19 |
Native Microbials, Inc. |
Microbial compositions and methods of use for canine enteropathy and dysbiosis
|
|
AU2021224185A1
(en)
*
|
2020-02-18 |
2022-09-15 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for identifying and treating subjects at risk of poor cancer survival
|
|
EP4108260A4
(en)
*
|
2020-02-21 |
2024-03-06 |
JSR Corporation |
COMPOSITION FOR RELIEVING PULMONARY HYPERTENSION, METHOD FOR PREDICTING PULMONARY HYPERTENSION
|
|
WO2021173972A1
(en)
*
|
2020-02-28 |
2021-09-02 |
Emory University |
Pentagalloyl glucose derived from schinus plants and methods of use
|
|
TW202146036A
(zh)
*
|
2020-04-28 |
2021-12-16 |
香港中文大學 |
針對ｃｏｖｉｄ－１９的微生物的治療和診斷用途
|
|
WO2021221110A1
(ja)
*
|
2020-04-29 |
2021-11-04 |
学校法人慶應義塾 |
Ｔｈ１細胞及び／又はＴｈ１７細胞の増殖又は活性化を誘導する小腸内細菌
|
|
GB202007452D0
(en)
*
|
2020-05-19 |
2020-07-01 |
Microbiotica Ltd |
Threrapeutic bacterial composition
|
|
US20230256033A1
(en)
*
|
2020-06-09 |
2023-08-17 |
Flagship Pioneering Innovations Vi, Llc |
Physiologically acceptable compositions containing microorganisms or microbial products
|
|
NL2025863B1
(en)
|
2020-06-19 |
2022-02-17 |
Acad Medisch Ct |
Fecal matter for treatment of cachexia
|
|
WO2022027040A2
(en)
|
2020-07-28 |
2022-02-03 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for treating infections of the gastrointestinal tract
|
|
IL300573A
(en)
|
2020-08-14 |
2023-04-01 |
Prolacta Bioscience Inc |
Breast milk oligosaccharide compositions for use with bacteriotherapy
|
|
CN112040091B
(zh)
|
2020-09-01 |
2023-07-21 |
先临三维科技股份有限公司 |
相机增益的调整方法和装置、扫描系统
|
|
IL301145A
(en)
|
2020-09-11 |
2023-05-01 |
Marvelbiome Inc |
Methods and uses of microbiome compositions
|
|
US12280037B2
(en)
|
2020-09-22 |
2025-04-22 |
Evofem Biosciences, Inc. |
Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
|
|
KR102470808B1
(ko)
*
|
2020-11-02 |
2022-11-28 |
주식회사 바이오미 |
염증성 장질환 예방 또는 치료용 조성물
|
|
MX2023006146A
(es)
*
|
2020-11-25 |
2023-07-31 |
Seres Therapeutics Inc |
Composiciones bacterianas diseñadas para tratar la enfermedad de injerto contra huésped.
|
|
WO2022168120A1
(en)
*
|
2021-02-03 |
2022-08-11 |
Tata Consultancy Services Limited |
Method and system for designing personalized therapeutics and diet based on functions of microbiome
|
|
CN114948986A
(zh)
*
|
2021-02-19 |
2022-08-30 |
星聚樊生物科技有限公司 |
中草药多醣及其细菌组成物改善疾病的用途
|
|
KR102373888B1
(ko)
|
2021-03-26 |
2022-03-15 |
주식회사 에이치이엠파마 |
머신러닝 모델을 이용하여 변비 유무를 판별하는 방법 및 진단장치
|
|
KR102373886B1
(ko)
|
2021-03-26 |
2022-03-15 |
주식회사 에이치이엠파마 |
머신러닝 모델을 이용하여 장염 유무를 판별하는 방법 및 진단 장치
|
|
CN113106042A
(zh)
*
|
2021-05-20 |
2021-07-13 |
广西壮族自治区兽医研究所 |
预防鸽形目念珠菌病的微生物菌剂、制剂及其制备方法和应用
|
|
NL2028324B1
(en)
|
2021-05-28 |
2022-12-12 |
Caelus Pharmaceuticals B V |
Insulin-sensitizing agent and butyrate-producing bacterium
|
|
US20240368558A1
(en)
*
|
2021-07-30 |
2024-11-07 |
Oncomedics |
Compositions and methods for decontaminating and culturing a gastrointestinal tract sample
|
|
KR102583365B1
(ko)
*
|
2021-08-11 |
2023-09-27 |
코스맥스 주식회사 |
마이크로코커스 안타르크티쿠스 균주 및 그의 피부 상태 개선 용도
|
|
KR20240117164A
(ko)
|
2021-11-11 |
2024-07-31 |
콘체르토 바이오사이언시스, 아이엔씨. |
피부 질환의 치료를 위한 미생물 조성물
|
|
CN116135205A
(zh)
*
|
2021-11-16 |
2023-05-19 |
葡萄王生技股份有限公司 |
戊醣片球菌gkp4用于制备改善肌少症之口服组成物的用途
|
|
EP4183403A1
(en)
*
|
2021-11-19 |
2023-05-24 |
Lietuvos Sveikatos Mokslu Universitetas |
Modification of fecal microbiota with capsules containing gram-positive bacteria
|
|
CA3239142A1
(en)
*
|
2021-12-02 |
2023-06-08 |
Mukesh Chatter |
Methods and uses of microbiome compositions, components, or metabolites for treating vagus nerve associated diseases, disorders, and conditions
|
|
KR102438867B1
(ko)
*
|
2022-03-11 |
2022-09-02 |
주식회사 바이오뱅크힐링 |
코프로코커스 캐터스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
|
WO2023132628A1
(ko)
*
|
2022-01-04 |
2023-07-13 |
주식회사 바이오뱅크힐링 |
신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
|
CN114317368B
(zh)
*
|
2022-01-05 |
2022-09-09 |
中国水产科学研究院南海水产研究所 |
一种利用盐渍四生球菌改善快速发酵鱼露风味的方法
|
|
US20250170163A1
(en)
*
|
2022-02-23 |
2025-05-29 |
Societe Des Produits Nestle S.A. |
Compositions and methods for reducing the occurrence of diarrhea by promoting blautia obeum in the gut microbiota
|
|
CA3255269A1
(en)
*
|
2022-04-26 |
2023-11-02 |
Cedars-Sinai Medical Center |
METHANOGENS AND PREVOTELLA USED AS MICROBIAL BACTERIA INCREASING THE PROPORTION AND NORMAL RATES OF BACTERIA FOR THE TREATMENT AND DIAGNOSIS OF DISEASES
|
|
CN114965764B
(zh)
*
|
2022-05-18 |
2024-12-31 |
陕西安宁云生生物技术有限公司 |
便秘的诊断和治疗
|
|
CN115466690A
(zh)
*
|
2022-05-19 |
2022-12-13 |
同济大学 |
一种地芽孢杆菌新菌种及其培养方法和应用
|
|
US12064451B2
(en)
*
|
2022-08-01 |
2024-08-20 |
Novel Biome Solutions Inc. |
Fecal microbiota transplant compositions and methods of manufacture
|
|
CN116790402B
(zh)
*
|
2023-01-14 |
2024-05-14 |
西北农林科技大学 |
一株具有抗炎特性的单形拟杆菌菌株、培养方法及应用
|
|
WO2025064408A1
(en)
|
2023-09-18 |
2025-03-27 |
The Broad Institute, Inc. |
Compositions and methods for treating cardiovascular disease
|
|
WO2025093777A1
(en)
|
2023-11-05 |
2025-05-08 |
Human Biome Institute S.A. |
Functional compositions and methods of use thereof in the treatment and recurrence prophylaxis of clostridioides difficile infection and restoration of healthy microbiota
|
|
WO2025147266A1
(en)
*
|
2024-01-06 |
2025-07-10 |
Jose Vega |
Method of mitigation of death from epileptic seizures
|
|
WO2025189001A2
(en)
*
|
2024-03-06 |
2025-09-12 |
University Of Florida Research Foundation, Incorporated |
Methods of reducing occurrence of neurodevelopmental disorders
|
|
CN118360215B
(zh)
*
|
2024-05-22 |
2025-03-07 |
吉林省农业科学院(中国农业科技东北创新中心) |
一种用于降低反刍动物甲烷排放量的菌剂及其制备方法以及含有该菌剂的配合饲料
|